Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 24, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 26, 2026
DirectorOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000816956-26-000011
Filed / recorded
Feb 26, 2026, 2:23 PM UTC
Added to OQRO
Oct 6, 2026, 10:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CONMED Corp
Issuer CIK
816956
Ticker
CNMD
Reporting person
Mark Kaye
Relationship
Director
Security
RSUs (Restricted Stock Units)
Table
Derivative (Table II)
Transaction date
Feb 24, 2026
Transaction code
M
Shares / units
152
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.